XML 162 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Deficit) (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]    
Schedule of Company Nonvested Shares

A summary of the Company’s nonvested shares (due to service based restrictions) as of June 30, 2024 and December 31, 2023, is presented below:

 

       Weighted Average 
   Number of   Gant Date 
Non-Vested Shares  Shares   Fair Value 
Balance - December 31, 2022   42,192   $1.40 
Granted   330,554    5.77 
Vested   (104,699)   6.72 
Cancelled/Forfeited   (153,711)   5.53 
Balance - December 31, 2023   114,336    6.40 
Granted   -    - 
Vested   (88,336)   5.15 
Cancelled/Forfeited   -    - 
Balance - June 30, 2024   26,000   $6.40 

A summary of the Company’s nonvested shares (due to service based restrictions) as of December 31, 2023 and 2022, is presented below: 

 

Non-Vested Shares  Number of
Shares
   Weighted Average
Gant Date
Fair Value
 
Balance - December 31, 2021   15,878   $8.18 
Granted   48,340    12.60 
Vested   (20,277)   53.80 
Cancelled/Forfeited   (1,750)   40.00 
Balance - December 31, 2022   42,191    1.40 
Granted   330,554    5.77 
Vested   (104,698)   6.72 
Cancelled/Forfeited   (153,711)   5.53 
Balance - December 31, 2023   114,336   $5.43 
Schedule of Stock Option Activity

Stock option transactions for the year ended December 31, 2023 is summarized as follows:

 

           Weighted       Weighted 
       Weighted   Average       Average 
       Average   Remaining   Aggregate   Grant 
   Number of   Exercise   Contractual   Intrinsic   Date 
Stock Options  Options   Price   Term (Years)   Value   Fair Value 
Outstanding - December 31, 2022   37,392   $19.05    3.68   $-   $- 
Vested and Exercisable - December 31, 2022   34,526   $19.44    3.47   $-   $- 
Unvested and non-exercisable - December 31, 2022   2,866   $14.36    4.16   $-   $- 
Granted   101,930   $17.41             $0.73 
Exercised   -   $-                
Cancelled/Forfeited   (139,322)  $17.85                       
Outstanding - December 31, 2023   -   $-    -   $-   $- 
Vested and Exercisable - December 31, 2023   -   $-    -   $-   $- 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $-   $- 

Stock option transactions for the years ended December 31, 2023 and 2022 are summarized as follows:

 

Stock Options  Number of
Options
   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
   Weighted
Average
Grant
Date
Fair Value
 
Outstanding - December 31, 2021   8,769   $35.60    3.25   $     -   $- 
Vested and Exercisable - December 31, 2021   8,769   $35.60    3.25   $-   $- 
Unvested and non-exercisable - December 31, 2021   -   $-    -   $-   $- 
Granted   28,623   $13.97             $12.49 
Exercised   -    -                
Cancelled/Forfeited   -    -                
Outstanding - December 31, 2022   37,392   $19.05    3.68   $-   $- 
Vested and Exercisable - December 31, 2022   34,526   $19.44    3.47   $-   $- 
Unvested and non-exercisable - December 31, 2022   2,866   $14.36    4.16   $-   $- 
Granted   101,930   $17.41             $0.73 
Exercised   -   $-                
Cancelled/Forfeited   (139,322)  $17.85                
Outstanding - December 31, 2023   -   $-    -   $-   $- 
Vested and Exercisable - December 31, 2023   -   $-    -   $-   $- 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $-   $- 
Schedule of Fair Value Assumptions

The fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions:

 

Expected term (years)   5.00 
Expected volatility   59% - 62%
Expected dividends   0%
Risk free interest rate   4.00%

The fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions:

 

Expected term (years)   5.00 
Expected volatility   59% - 62% 
Expected dividends   0%
Risk free interest rate   4.00%
 
Expected term (years)   5.00 
Expected volatility   62%
Expected dividends   0%
Risk free interest rate   1.64%
 
Schedule of Stock Warrant Activity

Warrant activity for the six months ended June 30, 2024 and the year ended December 31, 2023 are summarized as follows:

 

           Weighted     
           Average     
       Weighted   Remaining   Aggregate 
   Number of   Average   Contractual   Intrinsic 
Warrants  Warrants   Exercise Price   Term (Years)   Value 
Outstanding - December 31, 2022   81,452   $10.36    2.22   $82,756 
Vested and Exercisable - December 31, 2022   81,452   $10.36    2.22   $82,756 
Unvested - December 31, 2022   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - December 31, 2023   81,452   $10.36    1.22   $36,030 
Vested and Exercisable - December 31, 2023   81,452   $10.36    1.22   $36,030 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - June 30, 2024   81,452   $10.36    0.73   $3,199 
Vested and Exercisable - June 30, 2024   81,452   $10.36    0.73   $3,199 
Unvested and non-exercisable - June 30, 2024   -   $-    -   $- 

Warrant activity for the years ended December 31, 2023 and 2022 are summarized as follows:

 

Warrants  Number of
Warrants
   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Outstanding - December 31, 2021   81,452   $10.36    3.22   $- 
Vested and Exercisable - December 31, 2021   81,452   $10.36    3.22   $- 
Unvested - December 31, 2021   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - December 31, 2022   81,452   $10.36    2.22   $82,756 
Vested and Exercisable - December 31, 2022   81,452   $10.36    2.22   $82,756 
Unvested - December 31, 2022   -   $-    -   $- 
Granted   -                
Exercised   -                
Cancelled/Forfeited   -                
Outstanding - December 31, 2023   81,452   $10.36    1.22   $36,030 
Vested and Exercisable - December 31, 2023   81,452   $10.36    1.22   $36,030 
Unvested and non-exercisable - December 31, 2023   -   $-    -   $- 
Related Party [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Schedule of Classes of stock

The following represents the Company’s three (3) classes of stock:

  

June 30, 2024
  

Shares

Authorized

   Issued   Outstanding   Designated   Par Value   Votes
Per Share
 
                         
Preferred Stock                              
Preferred Stock   50,000,000                  $0.00001      
Series X        1    1    1   $0.00001    A 
                               
Common Stock                              
Series A   500,000,000    17,700,000    15,000,000        $0.00001    1 
Series B   500,000,000    11,800,000    10,000,000        $0.00001    10 
    1,000,000,000    29,500,000    25,000,000    -           

 

A - Series X will have a number of votes at any time equal to all of the number of votes held by all other voting equity securities, plus one share. Currently, the Series X preferred stockholder controls the Company through their super voting rights.

 

December 31, 2023
  

Shares

Authorized

   Issued   Outstanding   Designated   Par Value   Votes
Per Share
 
                         
Common Stock                              
Series A   500,000,000    17,700,000    15,000,000        $0.00001    1 
Series B   500,000,000    11,800,000    10,000,000            $0.00001    10 
    1,000,000,000    29,500,000    25,000,000    -           
 
Schedule of Company Nonvested Series A and B of Common Stock

The following is a summary of the Company’s non-vested Series A and B shares of common stock at June 30, 2024 and December 31, 2023, respectively:

 

       Weighted Average 
Non-Vested Shares  Number of Shares   Grant Date Fair Value 
Balance - December 31, 2023   -   $- 
Granted   4,500,000    2.03 
Vested   -    - 
Cancelled/Forfeited   -    - 
Balance - June 30, 2024   4,500,000   $2.03 
           
Unrecognized Compensation  $8,373,750      
           
Weighted average remaining period (years)   3.67